I don't think it's gimmicky. I think it's a tremendous statement of confidence in our program, ... In the world of interventional cardiology where patients are elderly, diseased, suffering, we don't really think of ourselves as providing gimmicks.
If you want me to comment on accelerating share decline, I guess I would have to say we don't see it,
We are very confident in our proposal. We think the (recall) issues are very manageable.
We see real flaws in the method. We're not dealing with a system that has a lot of precedent and has a lot of transparency.
We're going to run some new plays, and we think they're going to provide us some more momentum.
What we get is diversification for Boston Scientific and growth, and we get that through CRM. Clearly, CRM is the key asset here.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.